Cetuximab for the treatment of colorectal cancer.
By D. Jonker, C. O'Callaghan, C. Karapetis, J. Zalcberg, D. Tu, H. Au, S. Berry, M. Krahn, T. Price, R. Simes and 5 more. New England Journal of Medicine, 2007
1,016 citations recorded by the source corpus.
Subfields: Oncology
View Paper: https://www.semanticscholar.org/paper/d09b8eb9737dd7c7574898a30b8f3fde787136a2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
Citations in the corpus
- ERBB receptors: From oncogene discovery to basic science to mechanism-based cancer therapeutics (2014, result): “Despite this difference, phase III studies have demonstrated clinical efficacy similar to that of cetuximab (Douillard et al., 2014; Jonker et al., 2007; Van Cutsem et al., 2007, 2009).”